Mistletoe from Salicis specifically targeted CDK1 and 2, and Cyclin A, whereas mistletoe from Populi acted via CDK2 and Cyclin A and B. Low-grade bladder cancer appears to be more sensitive to mistletoe extracts than high-grade bladder cancer. This evidence concerns the gene CDK1 and urinary bladder carcinoma.